NCT00352534 · OUTCOME

Incidence of Renal Failure

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor · Source last updated 2026-06-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: Incidents
Interval / dispersion: Not reported
Time frame: During follow-up

What was measured

Number of renal failures defined as requiring dialysis or renal transplant as determined by low GFR during follow-up

Analysis population: Very low risk patients that have metachronous relapse.

Groups in this outcome

Very Low Risk

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Very Low Risk	116

Reported measurements

Source class 1

Values in Incidents · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Very Low Risk	0	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
0

denoms

counts
group Id
OG000
value
116
units
Participants

description

Number of renal failures defined as requiring dialysis or renal transplant as determined by low GFR during follow-up

groups

description
Very Low Risk
id
OG000
title
Very Low Risk

param Type

NUMBER

population Description

Very low risk patients that have metachronous relapse.

reporting Status

POSTED

time Frame

During follow-up

title

Incidence of Renal Failure

type

SECONDARY

unit Of Measure

Incidents

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice